Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,701-20,712 of 23,847
Drug study icon
Active Not RecruitingNCT05774665

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

This observational study is following people with Treatment Resistant Depression, Inflammation, or Overweight to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Multiple locations, including Atlanta
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Behavioral study icon
CompletedNCT00309452

Specialized Treatment Early in Psychosis (STEP)

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
SchizophreniaBehavioralFrom 16 Years to 45 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02990026

Specialty Mental Health Probation in North Carolina

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
AddictionBehavioralFrom 21 Years to 64 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Addiction
Behavioral study icon
CompletedNCT01607424

Specific Cognitive Remediation for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
SchizophreniaBehavioralFrom 18 Years to 45 Years
Countries
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
Drug study icon
CompletedNCT00269035

SPECT Study With SB-773812 In Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Barcelona
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Spain
Sponsor
GlaxoSmithKline
Condition
Schizophrenia
Behavioral study icon
Enrolling By InvitationNCT04040062

Spectral TMS (s-TMS)

This study is looking at care and outcomes for people with depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

In Los Angeles
DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.